Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15;58(4):548.
doi: 10.3390/medicina58040548.

Brain Metastases from Gynecologic Malignancies

Affiliations

Brain Metastases from Gynecologic Malignancies

Georgia Karpathiou et al. Medicina (Kaunas). .

Abstract

Background and Objectives: To present a series of brain metastases from gynecologic primaries and provide a summary of the relevant literature. Materials and Methods: We retrospectively review 18 patients with histologically confirmed brain metastases from gynecologic primaries and summarize the largest series of relative reports. Results: Six brain metastases were of endometrial primary and 12 of ovarian primary. In 3 cases (16.7%), diagnosis of brain metastases was made at presentation of the gynecologic primary; in the others, median time to development of brain metastasis was 34 (range, 6-115) months. Median survival after brain metastasis diagnosis was 5 (range, 1-89) months. Favorable prognostic factors were better performance status (p = 0.04) and, marginally, smaller metastasis size (p = 0.06). No differences in brain metastases between endometrial and ovarian primaries were found, except for the time interval from primary to brain metastases diagnosis, which was shorter for endometrial tumors (p = 0.05). A comprehensive summary of previous studies is provided. Conclusions: Performance status and smaller brain metastases size are good prognostic factors. Endometrial cancer brain metastases develop earlier than ovarian cancer brain metastases.

Keywords: brain metastasis; endometrial cancer; ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Ovarian high grade serous carcinoma infiltrating cerebellar tissue (left). Papillary structures and necrosis seen at the right. (B) Grade 2 endometrioid adenocarcinoma infiltrating glial tissue (left). (C) Grade 3 endometrioid adenocarcinoma infiltrating glial tissue (right). (D) Overall survival (OS) according to performance status.

References

    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7–30. doi: 10.3322/caac.21590. - DOI - PubMed
    1. Zhu L., Sun X., Bai W. Nomograms for Predicting Cancer-Specific and Overall Survival among Patients with Endometrial Carcinoma: A SEER Based Study. Front. Oncol. 2020;10:269. doi: 10.3389/fonc.2020.00269. - DOI - PMC - PubMed
    1. Arnold M., Rutherford M.J., Bardot A., Ferlay J., Andersson T.M., Myklebust T.Å., Tervonen H., Thursfield V., Ransom D., Shack L., et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol. 2019;20:1493–1505. doi: 10.1016/S1470-2045(19)30456-5. - DOI - PMC - PubMed
    1. Gardner A.B., Charo L.M., Mann A.K., Kapp D.S., Eskander R.N., Chan J.K. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: Most common locations and outcomes. Clin. Exp. Metastasis. 2020;37:107–113. doi: 10.1007/s10585-019-10007-0. - DOI - PubMed
    1. Zhang Y., Grant M.S., Stepp W.H., Clark L.H. Clinical characteristics of CNS metastases from primary gynecologic cancers. Gynecol. Oncol. Rep. 2019;30:100518. doi: 10.1016/j.gore.2019.100518. - DOI - PMC - PubMed